Psilocybin might be effective for treatment-resistant depression even with ongoing SSRI use, study suggests

Repeated low doses of psilocybin increase resilience to stress, lower compulsive actions, and strengthen cortical connections to the paraventricular thalamic nucleus in rats

Benefits of psychedelics in obsessive-compulsive disorder: LSD and psilocybin have strong potential for providing long-lasting relief of patients’ symptoms

Psychedelic mushrooms and quiet quitting: Psilocybin use tied to working fewer overtime hours

Naturalistic psilocybin use associated with persisting improvement in wellbeing

Single-Dose Psilocybin Treatment for Major Depressive Disorder

Oregon launches legal psilocybin access amid high demand and hopes

"…found no detectable difference in altered states of consciousness induced by 20 mg psilocybin, 100 µg LSD, or 500 mg mescaline”, and no severe side effects were noted for any substance"

Review suggested that "psilocybin may be an effective form of treatment for cancer-related psychiatric distress, treatment-resistant depression and addiction" and that "there are some reports of psilocybin being useful when treating obsessive-compulsive disorder and cluster headaches."

Psilocybin Decelerates Cellular Senescence